Overview

Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors

Status:
Terminated

Trial end date:
2005-08-01

Target enrollment:

Participant gender:

Summary

The objective of this study was to evaluate the effect of age (geriatric) and renal function on the safety, efficacy and pharmacokinetics of OctreoScan at the recommended clinical dose in this patient population.

Phase:

Phase 4

Details

Lead Sponsor:

Mallinckrodt

Treatments:

Somatostatin